Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sehhoon Park

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Translational Lung Cancer Research|October 19, 2023
Real-world clinical evidence of lazertinib use in acquired <i>EGFR</i> T790M mutated non-small cell lung cancerSehhoon Park, Hyun Ae Jung, Se-Hoon Lee, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 21, 2023
Prognostic significance of body mass index in small-cell lung cancer: Exploring the relationship with skeletal muscle statusYong Jae Kwon, Young Cheol Yoon, Hyun Su Kim, et al.
Cancer|March 23, 2022
Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinomaSehhoon Park, Dongryul Oh, Yoon-La Choi, et al.
BMB Reports|June 22, 2021
Paired analysis of tumor mutation burden calculated by targeted deep sequencing panel and whole exome sequencing in non-small cell lung cancerSehhoon Park, Chung Lee, Bo Mi Ku, et al.
The Korean Journal of Internal Medicine|February 3, 2016
Mild form of Guillain-Barré syndrome in a patient with primary Epstein-Barr virus infectionSe Yong Kim, Kang-Won Choe, Sehhoon Park, et al.
Biology|October 10, 2020
Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon <i>EGFR</i> Mutations: Are They Different from Those with Common <i>EGFR</i> Mutations?Hyun Ae Jung, Sehhoon Park, Jong-Mu Sun, et al.
Cancer Research and Treatment|July 14, 2023
First-Line Alectinib vs. Brigatinib in Advanced Non-Small Cell Lung Cancer with ALK Rearrangement: Real-World DataYoungkyung Jeon, Sehhoon Park, Hyun Ae Jung, et al.
Cancer Research and Treatment|October 13, 2022
EGFR Mutation-Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain MetastasisHongsik Kim, Sehhoon Park, Hyun Ae Jung, et al.
Journal of Neuro-Oncology|September 8, 2020
Diagnostic accuracy of MR imaging of patients with leptomeningeal seeding from lung adenocarcinoma based on 2017 RANO proposal: added value of contrast-enhanced 2D axial T2 FLAIRMinjung Seong, Sehhoon Park, Sung Tae Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|March 17, 2024
Survival benefit in EGFR-wild and ALK negative NSCLC patients who participate in clinical trials compared to standard-of-care: Propensity-matched analysisHyun Ae Jung, Boram Park, Sehhoon Park, et al.
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Translational Lung Cancer Research|October 19, 2023
Real-world clinical evidence of lazertinib use in acquired <i>EGFR</i> T790M mutated non-small cell lung cancerSehhoon Park, Hyun Ae Jung, Se-Hoon Lee, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 21, 2023
Prognostic significance of body mass index in small-cell lung cancer: Exploring the relationship with skeletal muscle statusYong Jae Kwon, Young Cheol Yoon, Hyun Su Kim, et al.
Cancer|March 23, 2022
Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinomaSehhoon Park, Dongryul Oh, Yoon-La Choi, et al.
BMB Reports|June 22, 2021
Paired analysis of tumor mutation burden calculated by targeted deep sequencing panel and whole exome sequencing in non-small cell lung cancerSehhoon Park, Chung Lee, Bo Mi Ku, et al.
The Korean Journal of Internal Medicine|February 3, 2016
Mild form of Guillain-Barré syndrome in a patient with primary Epstein-Barr virus infectionSe Yong Kim, Kang-Won Choe, Sehhoon Park, et al.
Biology|October 10, 2020
Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon <i>EGFR</i> Mutations: Are They Different from Those with Common <i>EGFR</i> Mutations?Hyun Ae Jung, Sehhoon Park, Jong-Mu Sun, et al.
Cancer Research and Treatment|July 14, 2023
First-Line Alectinib vs. Brigatinib in Advanced Non-Small Cell Lung Cancer with ALK Rearrangement: Real-World DataYoungkyung Jeon, Sehhoon Park, Hyun Ae Jung, et al.
Cancer Research and Treatment|October 13, 2022
EGFR Mutation-Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain MetastasisHongsik Kim, Sehhoon Park, Hyun Ae Jung, et al.
Journal of Neuro-Oncology|September 8, 2020
Diagnostic accuracy of MR imaging of patients with leptomeningeal seeding from lung adenocarcinoma based on 2017 RANO proposal: added value of contrast-enhanced 2D axial T2 FLAIRMinjung Seong, Sehhoon Park, Sung Tae Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|March 17, 2024
Survival benefit in EGFR-wild and ALK negative NSCLC patients who participate in clinical trials compared to standard-of-care: Propensity-matched analysisHyun Ae Jung, Boram Park, Sehhoon Park, et al.
Pageof 13